1. Zlokachestvennye novoobrazovaniya v Rossii v 2020 g. (zabolevaemost' i smertnost') /pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shakhzadovoi. M.: MNIOI im. P.A. Gertsena — filial FGBU «NMITs radiologii» Minzdrava Rossii, 2021. [Malignant tumors in Russiain 2020 (morbidity and mortality) /Ed by. AD Kaprina, VV Starinskogo, GV Petrovoi. Moscow: P.A. Herzen MSIOI — filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2021 (In Russ.)].
2. World Health Organization. The Global Cancer Observatory (vklyuchaya bazu dannykh GLOBOCAN 2018). Geneva: WHO; 2021.
3. Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. NY: Garland Science; 2012. p. 1205-1268.
4. Bit-Sava E.M., Belogurova M.B. Nasledstvennyi rak molochnoi zhelezy. Sibirskii onkologicheskii zhurnal. 2013;55(1):75–81. [Bit-Sava EM, Belogurova NB. Hereditary breast cancer. Siberian journal of oncology. 2013;55(1):75–81. (In Russ.)].
5. European Society for Medical Oncology. BRCA in breast cancer: ESMO Clinical Recommendations. 2018.